Terms: = Colorectal cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
220 results:
1. Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn's disease: a case-control study.
Rodríguez-Lago I; Aduna M; Ramírez de la Piscina P; Merino O; Carrascosa J; Higuera R; Maíz A; Zapata E; Cabriada JL; Barreiro-de Acosta M
Int J Colorectal Dis; 2024 Jun; 39(1):92. PubMed ID: 38871954
[TBL] [Abstract] [Full Text] [Related]
2. Short-term outcomes of surgical treatment for primary ileocaecal Crohn's disease: Results of the Crohn's(urg) study, a multicentre, retrospective, comparative analysis between inflammatory and complicated phenotypes.
Avellaneda N; Pellino G; Maroli A; Tottrup A; Bislenghi G; Colpaert J; D'Hoore A; Carvello M; Giorgi L; Juachon P; Harsløf S; de Buck Van Overstraeten A; Olivera PA; Gomez J; Holubar SD; Naranjo EL; Steele SR; Merchea A; Shaker A; Gallostra MM; Kraft M; Kotze PG; Maruyama BY; Wexner SD; Garoufalia Z; Chen Z; Hahnloser D; Rrupa D; Buskens C; Haanappel A; Warusavitarne J; Williams KJ; Christensen P; Wolthuis A; Potolicchio A; Spinelli A
Colorectal Dis; 2024 Jul; 26(7):1415-1427. PubMed ID: 38858815
[TBL] [Abstract] [Full Text] [Related]
3. ARHGAP4 promotes colon cancer metastasis through the TGF-β signaling pathway and may be associated with T cell exhaustion.
Jiang S; Tang Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
Biochem Biophys Res Commun; 2024 Aug; 722():150172. PubMed ID: 38805788
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
[TBL] [Abstract] [Full Text] [Related]
5. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions.
Sharma S; Singh N; Turk AA; Wan I; Guttikonda A; Dong JL; Zhang X; Opyrchal M
World J Gastroenterol; 2024 Apr; 30(13):1815-1835. PubMed ID: 38659481
[TBL] [Abstract] [Full Text] [Related]
6. [Expression of immune checkpoints PD-L1, ctla4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
7. Exploring the clinical significance of IL-38 correlation with PD-1, ctla-4, and FOXP3 in colorectal cancer draining lymph nodes.
Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
[TBL] [Abstract] [Full Text] [Related]
8. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.
Fróes RSB; Andrade AR; Faria MAG; de Souza HSP; Parra RS; Zaltman C; Dos Santos CHM; Bafutto M; Quaresma AB; Santana GO; Luporini RL; de Lima Junior SF; Miszputen SJ; de Souza MM; Herrerias GSP; Junior RLK; do Nascimento CR; Féres O; de Barros JR; Sassaki LY; Saad-Hossne R
Sci Rep; 2024 Feb; 14(1):4314. PubMed ID: 38383742
[TBL] [Abstract] [Full Text] [Related]
9. [Inflammatory bowel diseases: Transformation of representations. A review].
Maev IV; Bakulin IG; Skalinskaya MI; Skazyvaeva EV
Ter Arkh; 2023 Dec; 95(12):1064-1074. PubMed ID: 38158940
[TBL] [Abstract] [Full Text] [Related]
10. Prolonged preoperative sedentary time is a risk factor for postoperative ileus in patients with colorectal cancer: a propensity score-matched retrospective study.
Yanagisawa T; Tatematsu N; Horiuchi M; Migitaka S; Yasuda S; Itatsu K; Kubota T; Sugiura H
Support Care Cancer; 2023 Dec; 32(1):54. PubMed ID: 38129532
[TBL] [Abstract] [Full Text] [Related]
11. Post-colonoscopy rectal cancer in Swedish patients with Crohn's disease 2001-2015: a population-based case review study.
Stjärngrim J; Ekbom A; Widman L; Hultcrantz R; Forsberg A
Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1334-1340. PubMed ID: 37942755
[TBL] [Abstract] [Full Text] [Related]
12. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study.
Rennebaum F; Demmig C; Schmidt HH; Vollenberg R; Tepasse PR; Trebicka J; Gu W; Ullerich H; Kabar I; Cordes F
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895106
[TBL] [Abstract] [Full Text] [Related]
13. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease.
Wang MH; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Monroe K; Nix BD; Newberry RD; Faubion WA
BMJ Open Gastroenterol; 2023 Oct; 10(1):. PubMed ID: 37832963
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a seven autophagy-related gene pairs signature for the diagnosis of colorectal cancer using the RankComp algorithm.
Song QS; Wu HJ; Lin Q; Tang YK
J Bioinform Comput Biol; 2023 Jun; 21(3):2350012. PubMed ID: 37325865
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of essential and toxic elemental concentrations in tumor and non-tumor tissues with risk of colorectal carcinoma in Pakistan.
Qayyum MA; Farooq T; Baig A; Bokhari TH; Anjum MN; Mahmood MH; Ashraf AR; Muddassir K; Ahmad M
J Trace Elem Med Biol; 2023 Sep; 79():127234. PubMed ID: 37302218
[TBL] [Abstract] [Full Text] [Related]
16. Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
Suttichaimongkol T; Loftus EV
Inflamm Bowel Dis; 2024 Apr; 30(4):547-553. PubMed ID: 37279944
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic significances of PD-L1- and ctla-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
[TBL] [Abstract] [Full Text] [Related]
18. Risk of anorectal cancer in patients with Crohn's disease and perianal fistula: a nationwide Danish cohort study.
El-Hussuna A; Lemser CE; Iversen AT; Allin KH; Jess T
Colorectal Dis; 2023 Jul; 25(7):1453-1459. PubMed ID: 37086006
[TBL] [Abstract] [Full Text] [Related]
19. Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease.
Dai Z; Zhang J; Xu W; Du P; Wang Z; Liu Y
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047025
[TBL] [Abstract] [Full Text] [Related]
20. Inflammatory Bowel Disease and Risk of colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden.
Axelrad JE; Olén O; Söderling J; Roelstraete B; Khalili H; Song M; Faye A; Eberhardson M; Halfvarson J; Ludvigsson JF
J Crohns Colitis; 2023 Oct; 17(9):1395-1409. PubMed ID: 36994851
[TBL] [Abstract] [Full Text] [Related]
[Next]
